NIHR Maudsley BRC Blog

Our latest news and events

Working with students and teachers to evaluate secondary school stress workshops

June Brown is the lead for Brief Evaluation of Stress Workshops in Secondary Schools (BESST) and a reader/associate professor in Clinical Psychology at the Institute of Psychiatry, Psychology & Neuroscience (IoPPN), King's College London. In this blog she describes how a small pilot with schools in South London has now led to a national clinical trial funded by the NIHR with 900 students across 57 schools. 

By NIHR Maudsley BRC at 8 Jun 2023

New collaboration with digital therapeutics company to investigate preventable opioid respiratory deaths

A clinical trial that is collecting data on the features of opioid overdoses within the safety of a clinical setting will be integrating a monitoring platform into the research to investigate how to prevent deaths from breathing problems in opioid users.

By NIHR Maudsley BRC at 20 Jan 2022

Next generation of rapid-acting antidepressants: Can ketamine help prevent suicide?

Naghmeh Nikkheslat is a Senior Research Associate at the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) who is working on a project funded by the NIHR Maudsley BRC to investigate the use of ketamine as a medication for depression. In this blog, she talks about her research into depression and the immune system and what we currently know about ketamine as an anti-inflammatory antidepressant in psychiatric emergencies.

By NIHR Maudsley BRC at 10 Jan 2022

Psilocybin, in 10mg or 25mg doses, has no detrimental effects in healthy people

New research from King’s College London, in partnership with COMPASS Pathways and supported by NIHR Maudsley BRC, has established that psilocybin can be safely administered at doses of either 10mg or 25mg to up to six participants at the same time.

By NIHR Maudsley BRC at 4 Jan 2022

No convincing scientific evidence that hangover cures work, according to new research

A new systematic review has found only very low-quality evidence that substances claiming to treat or prevent alcohol-induced hangover work.

By NIHR Maudsley BRC at 1 Jan 2022